A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Novartis Europharm Limited, against the decision of the State Institute for Drug Control from 30. 7. 2020, under the no. SUKLS186193/2020:
More information: MZCR.cz.
Published 20. 10. 2020.